Pro Share Advisors LLC Adma Biologics, Inc. Transaction History

Pro Share Advisors LLC

  • $48.7 Billion
  • Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 60,789 shares of ADMA stock, worth $910,011. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60,789
Previous 64,881 6.31%
Holding current value
$910,011
Previous $1.29 Million 14.06%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
SELL
$17.6 - $24.51 $72,019 - $100,294
-4,092 Reduced 6.31%
60,789 $1.11 Million
Q1 2025

May 08, 2025
SELL
$15.44 - $20.61 $222,413 - $296,887
-14,405 Reduced 18.17%
64,881 $1.29 Million
Q4 2024

Feb 13, 2025
BUY
$15.62 - $22.62 $287,017 - $415,642
18,375 Added 30.17%
79,286 $1.36 Million
Q3 2024

Nov 13, 2024
BUY
$11.21 - $20.03 $202,318 - $361,501
18,048 Added 42.11%
60,911 $1.22 Million
Q2 2024

Aug 13, 2024
SELL
$5.98 - $11.18 $68,351 - $127,787
-11,430 Reduced 21.05%
42,863 $479,000
Q1 2024

May 08, 2024
BUY
$4.4 - $6.74 $20,108 - $30,801
4,570 Added 9.19%
54,293 $358,000
Q4 2023

Feb 14, 2024
BUY
$3.08 - $4.52 $23,577 - $34,600
7,655 Added 18.2%
49,723 $224,000
Q3 2023

Nov 13, 2023
BUY
$3.47 - $4.61 $1,006 - $1,336
290 Added 0.69%
42,068 $150,000
Q2 2023

Aug 10, 2023
BUY
$3.12 - $4.22 $5,681 - $7,684
1,821 Added 4.56%
41,778 $154,000
Q1 2023

May 11, 2023
SELL
$3.01 - $3.87 $695 - $893
-231 Reduced 0.57%
39,957 $132,000
Q4 2022

Feb 02, 2023
BUY
$2.47 - $3.88 $7,864 - $12,353
3,184 Added 8.6%
40,188 $155,000
Q3 2022

Nov 04, 2022
BUY
$2.03 - $2.86 $1,693 - $2,385
834 Added 2.31%
37,004 $90,000
Q2 2022

Aug 01, 2022
BUY
$1.43 - $2.2 $22,744 - $34,991
15,905 Added 78.49%
36,170 $71,000
Q1 2022

May 10, 2022
SELL
$1.28 - $1.83 $9,358 - $13,379
-7,311 Reduced 26.51%
20,265 $37,000
Q4 2021

Feb 08, 2022
BUY
$1.09 - $1.66 $30,057 - $45,776
27,576 New
27,576 $39,000
Q2 2021

Aug 13, 2021
SELL
$1.51 - $2.07 $26,594 - $36,456
-17,612 Closed
0 $0
Q1 2021

May 14, 2021
BUY
$1.67 - $2.95 $5,025 - $8,876
3,009 Added 20.61%
17,612 $31,000
Q4 2020

Feb 09, 2021
SELL
$1.8 - $2.56 $12,040 - $17,123
-6,689 Reduced 31.42%
14,603 $28,000
Q3 2020

Nov 13, 2020
SELL
$2.04 - $3.74 $1,399 - $2,565
-686 Reduced 3.12%
21,292 $51,000
Q2 2020

Aug 03, 2020
BUY
$2.42 - $3.29 $23,970 - $32,587
9,905 Added 82.04%
21,978 $64,000
Q1 2020

May 15, 2020
SELL
$1.5 - $4.59 $11,368 - $34,787
-7,579 Reduced 38.57%
12,073 $35,000
Q4 2019

Feb 12, 2020
BUY
$3.89 - $5.15 $76,446 - $101,207
19,652 New
19,652 $79,000

Others Institutions Holding ADMA

# of Institutions
402
Shares Held
196M
Call Options Held
2.08M
Put Options Held
1.56M
View Full List

About ADMA BIOLOGICS, INC.

ADMA Quotes by TradingView
  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $2.94B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email